Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymol 4% solution in children with mild to moderate acute otitis media
2009-009037-14Phase 2Completed
- Sponsor
- Auris Health
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute otitis media (AOM) comparing Thymol 4% solution with Placebo solution (2 arms). Primary endpoints: Treatment response / healing and Safety and tolerability. Started Jan 2009; status: completed.
02
Drugs
thymol
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on 2009-009037-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009037-14.